"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey".

A recent meta-analysis found absence of benefit of CS in critically ill COVID-19 patients but signalled a trend towards benefit in patients with acute respiratory distress syndrome (ARDS) which did not reach statistical significance [ 26 ].

also in 111,027 other papers

Overall trends from the questionnaire (Baseline for a comparative analysis) • There was an overall trend towards advocating HCQ both as prophylaxis for HCP (44.55%) as well as those diagnosed with mild-moderate COVID-19 (45.04%) and severe COVID-19 (43.58%) ( Table 3 ). • A very similar trend was observed with azithromycin use in SARS-CoV-2 patients with mild-moderate (51.94%) and severe disease (46%)

also in 4,871 other papers